The Netherlands, explained in English · Saturday 21 November 2026Sat 21 Nov

Politics

Cabinet warns higher medicine prices could squeeze other Dutch care

In answers to parliamentary questions, the cabinet says US pressure on drug prices could push up spending on medicines and leave less money for other care.

Ministry building on Parnassusplein in The Hague
iIllustrative photo: Fred Romero from Paris, France / CC BY 2.0

The cabinet says higher spending on medicines would put more pressure on the availability of care in the Netherlands. Health minister Sophie Hermans sent the answers to the Tweede Kamer on 19 November 2026, replying to questions from D66 MP Vervuurt submitted on 30 October.

Healthcare funds are not unlimited, the cabinet says. More spending on medicines can leave less money for other forms of care, a "crowding-out effect" (verdringingseffect) that causes health loss elsewhere in society. The cabinet says the exact effect cannot be determined with certainty.

If asking prices rise, the Zorginstituut could rule that more medicines are not cost-effective, the cabinet says. Those medicines would then stay out of the insured package, unless the company is willing to lower its price to a socially acceptable level.

The cabinet wants spending on medicines to be proportionate to the health gain they deliver. Its starting point is that medicines with added value for patients should be available at a socially acceptable price.

The US trade representative has raised concerns about the medicine pricing and reimbursement policies of 14 EU member states, including Belgium, France, Germany and Spain. The cabinet says this shows US attention is not limited to the UK and Germany.

Germany is so far the only European country against which the United States has formally opened a specific investigation into medicine pricing policy, according to the cabinet.

The cabinet says the Dutch consequences of price rises accepted elsewhere under geopolitical tension are hard to predict. If that happens in countries with a large share of the European market, such as Germany, it expects companies to press for higher prices and spending to rise.

See more of NLnow in Google: add it as a preferred source